T1	Participants 320 399	virologically suppressed patients (HIV-1 RNA <400 copies/mL for > or =3 months)
T2	Participants 753 772	Eighty-one patients
T3	Participants 103 122	suppressed patients
T4	Participants 1576 1621	Patients who experience virologic suppression
